Andrew S. Davis - 19 May 2023 Form 4 Insider Report for Silk Road Medical Inc

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
19 May 2023
Net transactions value
-$132,528
Form type
4
Filing time
04 Aug 2023, 17:31:40 UTC
Previous filing
03 May 2023
Next filing
10 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $13,268 +507 +0.44% $26.17 116,121 19 May 2023 Direct F1
transaction SILK Common Stock Sale $145,797 -6,587 -5.7% $22.13 109,534 03 Aug 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
F2 Represents shares that have been sold by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.